Biologicals

Papers
(The TQCC of Biologicals is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops24
Aims and Scope/Editorial Board/Publishing Details23
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA21
Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products15
Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA14
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop14
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency13
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis12
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model12
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression11
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques11
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report10
Aims and Scope/Editorial Board/Publishing Details10
A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus10
The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report10
Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions10
Establishing potency and stability release specifications using alternative ATP assay of BCG Tokyo 172-1 vaccine used in Thailand9
Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines9
Animal cell substrates for the production of biologicals: An introduction to WHO documents9
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab9
Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics9
Vaccination and surveillance for high pathogenicity avian influenza in poultry—current situation and perspectives9
Replacement of in vivo leptospirosis vaccine potency testing in the United States8
IABS/DCVMN webinar on next generation sequencing8
Report of the fourth conference on next-generation sequencing (NGS) for adventitious virus detection in biologics for humans and animals: Validation and implementation of NGS8
Collaborative study for the calibration of a replacement International Standard for Diphtheria Antitoxin Equine7
Ethical approval for controlled human infectious model clinical trial protocols – A workshop report7
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report6
Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y6
Evaluation of the focus reduction neutralization and ELISA tests compared to the plaque reduction neutralization test for the detection of antibodies against measles virus6
A new Japanese regulatory perspective regarding the indication extrapolation between approved intravenous immunoglobulins (IVIg) products based on comparability assessments of quality attributes6
A rapid and simple sterility test method based on solid culture medium containing blood5
Development and evaluation of an external quality control and internal quality control containing real-time RT-PCR assay for the detection of o'nyong-nyong virus5
In silico discovery of epitopes of gag and env proteins for the development of a multi-epitope vaccine candidate against Maedi Visna Virus using reverse vaccinology approach5
Aims and Scope/Editorial Board/Publishing Details4
Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients4
Aims and Scope/Editorial Board/Publishing Details4
Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities4
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report4
Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology4
Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines4
Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report4
Glycoconjugate content quantification to assess vaccine potency: A simplified approach4
Mass spectrometry analysis of bovine tuberculins - 3R potential in batch potency testing4
Aims and Scope/Editorial Board/Publishing Details4
Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines4
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities4
0.18568110466003